Log in to save to my catalogue

Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy

Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_265106

Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy

About this item

Full title

Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2018-02, Vol.378 (7), p.625-635

Language

English

Formats

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

In this phase 3 trial, among children with later-onset spinal muscular atrophy, those who received nusinersen had improvement in motor-function scores and those who underwent a sham procedure did not.

Alternative Titles

Full title

Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_gup_ub_gu_se_265106

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_265106

Other Identifiers

ISSN

0028-4793,1533-4406

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1710504